πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 30 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12383535

Hydrogen peroxide-responsive KEAP1-NRF2 ppi inhibitor prodrug, and preparation method ther

CHINA PHARMACEUTICAL UNIVERSITY Β· Granted Tue Aug 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12331058

SHP2 and CDK4/6 dual-target inhibitory compound and pharmaceutical composition containing

CHINA PHARMACEUTICAL UNIVERSITY Β· Granted Tue Jun 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12310944

Selective butyrylcholinesterase inhibitor or pharmaceutically acceptable salt thereof, pre

CHINA PHARMACEUTICAL UNIVERSITY Β· Granted Tue May 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12226476

Helper epitope peptide and application thereof

CHINA PHARMACEUTICAL UNIVERSITY Β· Granted Tue Feb 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12144881

Cosmetic composition containing Ξ±-mangostin, method for preparation, and uses thereof

CHINA PHARMACEUTICAL UNIVERSITY Β· Granted Tue Nov 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11993603

Preparation for 6-amino-1H-pyrazolo[3,4-d]pyrimidine-based JAK kinase inhibitor and applic

CHINA PHARMACEUTICAL UNIVERSITY Β· Granted Tue May 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11970523

Long-acting oxyntomodulin hybrid peptide, preparation method therefor, and application the

CHINA PHARMACEUTICAL UNIVERSITY Β· Granted Tue Apr 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11773057

Naphthalenesulfonamide compound, preparation method, and application

CHINA PHARMACEUTICAL UNIVERSITY Β· Granted Tue Oct 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11572359

PARP/PI3K double-target inhibit containing pyridopyrimidine structure

CHINA PHARMACEUTICAL UNIVERSITY Β· Granted Tue Feb 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11541032

Composition containing sumo inhibitor and application

CHINA PHARMACEUTICAL UNIVERSITY Β· Granted Tue Jan 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11504385

Proteolysis targeting chimeric molecule, preparation method, and application

CHINA PHARMACEUTICAL UNIVERSITY Β· Granted Tue Nov 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11479545

Compositions and methods for inhibiting phenyl triazole MLL1-WDR5 protein-protein interact

CHINA PHARMACEUTICAL UNIVERSITY Β· Granted Tue Oct 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11304926

Application of transient receptor potential cation channel TRPV3 in developing drug for pr

CHINA PHARMACEUTICAL UNIVERSITY Β· Granted Tue Apr 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11085022

Inflammation-targeted neutrophil granulocyte drug delivery system and use thereof

CHINA PHARMACEUTICAL UNIVERSITY Β· Granted Tue Aug 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11078250

High-activity long-acting hypoglycemic fusion protein as well as preparation method and me

CHINA PHARMACEUTICAL UNIVERSITY Β· Granted Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11021454

Type of aryl benzofuran amidated derivative and medical use thereof

CHINA PHARMACEUTICAL UNIVERSITY Β· Granted Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11014895

Heterocyclic urea compound, and drug composition and application thereof

CHINA PHARMACEUTICAL UNIVERSITY Β· Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10875903

Bifunctional fusion proteins to inhibit angiogenesis in tumor microenvironment and to acti

CHINA PHARMACEUTICAL UNIVERSITY Β· Granted Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10639289

Application of neuraminidase and inhibitors thereof in myocardial ischemia and myocardial

CHINA PHARMACEUTICAL UNIVERSITY Β· Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10526370

Pentapeptide associated with integrin receptor alpha vbeta3

CHINA PHARMACEUTICAL UNIVERSITY Β· Granted Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10442759

1-sulfonamido-4-aryloxy compounds, and preparation method and medicinal application thereo

CHINA PHARMACEUTICAL UNIVERSITY Β· Granted Tue Oct 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9943524

Use of alkaloid in preparing pharmaceutical compositions for preventing or treating pulmon

CHINA PHARMACEUTICAL UNIVERSITY Β· Granted Tue Apr 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9822089

R type of resveratrol dimer, preparation process therefor and purpose thereof in lowering

CHINA PHARMACEUTICAL UNIVERSITY Β· Granted Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8859527

Inclusion complex of deoxypodophyllotoxin of cyclodextrin, preparation method, use for tre

CHINA PHARMACEUTICAL UNIVERSITY Β· Granted Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted